Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Sales/Fixed Asset

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Sales/Fixed Asset(x) 0.890.760.861.071.47

What is the latest Sales/Fixed Asset ratio of NATCO PHARMA ?

The latest Sales/Fixed Asset ratio of NATCO PHARMA is 0.89 based on Mar2023 Consolidated results.
Year Sales/Fixed Asset
Mar20230.89
Mar20220.76
Mar20210.86
Mar20201.07
Mar20191.47

How is Sales/Fixed Asset of NATCO PHARMA Trending?

Years Sales/Fixed Asset % Change
Mar2023 0.89
17.11
Mar2022 0.76
-11.63
Mar2021 0.86
-19.63
Mar2020 1.07
-27.21
Mar2019 1.47 -

Other Financial Ratios of NATCO PHARMA


Compare Sales/Fixed Asset ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹18,433.0 Cr 2.1% 2.1% 65.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹351,910.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,369.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹112,930.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹106,515.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,161.7 Cr 0.9% -1.5% 32.2% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.1%

2.1%

65.5%

SENSEX

1.9%

2.1%

21.7%


You may also like the below Video Courses